Interleukin-6: A Potential Target for Post-Thrombotic Syndrome
- 6 December 2010
- journal article
- Published by Elsevier BV in Annals of Vascular Surgery
- Vol. 25 (2), 229-239
- https://doi.org/10.1016/j.avsg.2010.09.003
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Statins suppress interleukin‐6‐induced monocyte chemo‐attractant protein‐1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cellsBritish Journal of Pharmacology, 2010
- Vein Wall Remodeling after Deep Vein Thrombosis: Differential Effects of Low Molecular Weight Heparin and DoxycyclineAnnals of Vascular Surgery, 2010
- Thrombogenesis with continuous blood flow in the inferior vena cavaThrombosis and Haemostasis, 2010
- Critical Role for IL-6 in Hypertrophy and Fibrosis in Chronic Cardiac Allograft RejectionAmerican Journal of Transplantation, 2009
- Prevention of venous thrombosis by preoperative glycyrrhizin infusion in a rat modelJournal of Orthopaedic Science, 2008
- Tocilizumab: The first interleukin-6-receptor inhibitorAmerican Journal of Health-System Pharmacy, 2008
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trialThe Lancet, 2008
- Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumabAnnals Of The Rheumatic Diseases, 2007
- Deep vein thrombosis resolution is not accelerated with increased neovascularizationJournal of Vascular Surgery, 2004
- ABC of vascular diseases. Deep venous insufficiency and occlusion.BMJ, 1992